Zimbabwe MCAZ Pharmaceutical Import & Registration

MCAZ: The Regulator

The Medicines Control Authority of Zimbabwe (MCAZ) was established under the Medicines and Allied Substances Control Act (Chapter 15:03) of 1997. It is the national regulatory authority responsible for ensuring the quality, safety, and efficacy of medicines, medical devices, and allied substances in Zimbabwe.

MCAZ's core functions:

• Product registration and marketing authorization
• Inspecting manufacturing facilities (GMP audits)
• Issuing import and export permits
• Pharmacovigilance and post-market surveillance
• Clinical trial authorization
• Licensing of pharmacies and drug outlets

MCAZ is headquartered in Harare (at the MCAZ Complex on Seke Road) with regional offices in Bulawayo and Mutare. The authority has implemented an electronic submission system, though the system is less sophisticated than regional peers. Paper submissions are still accepted and common.

Registration Pathways & Product Categories

MCAZ offers several registration pathways aligned with SADC and WHO standards.

Pathway 1: Full Registration (New Chemical Entities / NCEs)

Full clinical trial data required. Timeline: 12-24 months. Rare for most exporters.

Pathway 2: Abridged Registration (Generic Products)

The most common pathway for imports. Requires bioequivalence data or reference to a registered product. Timeline: 9-15 months.

Pathway 3: SADC Harmonization (ZaZiBoNa)

This is the strategic pathway for Zimbabwe. The ZaZiBoNa collaborative registration process involves Zimbabwe, Zambia, Botswana, Namibia, and South Africa. One dossier assessed by multiple SADC countries. Timeline: 6-10 months for collaborative assessment.

Pathway 4: WHO PQ Recognition (Fast-Track)

Products with WHO Prequalification receive priority review. Timeline: 5-8 months.

Pathway 5: SRA Recognition

Products approved by US FDA, EMA, SAHPRA, or other SRAs receive accelerated review. Timeline: 6-9 months.

Pathway 6: Locally Manufactured Products

Products manufactured in Zimbabwe receive priority processing (4-7 months) and government procurement preferences.

Prerequisites: What You Need Before Applying

Before submitting to MCAZ, ensure these items are in place.

• Appoint a Local Agent/Distributor: Foreign manufacturers must appoint a Zimbabwean company with a valid MCAZ import license. This agent will hold the registration and manage importation.
• Execute a Power of Attorney (PoA): A notarized document authorizing your local agent. Must be legalized at the Zimbabwean embassy.
• Obtain a Certificate of Pharmaceutical Product (CPP): Issued by your home regulator. Must be in WHO format, less than 2 years old, and legalized.
• Prepare Your Dossier in CTD Format: MCAZ follows the CTD format (Modules 1-5).
• WHO PQ or SRA Approval (if available): The single most valuable document for accelerated registration.
• Product Samples: Required for MCAZ laboratory testing in Harare.

Step-by-Step Registration Process

Here's the actual process for registering with MCAZ. Be prepared for a bureaucratic process with potential delays.

Step 1: Appoint a Local Agent

Sign an agreement with a Zimbabwean importer. Verify their MCAZ license and their experience with product registration and NatPharm tenders.

Step 2: Execute and Legalize Power of Attorney

Draft PoA, notarize, legalize at Zimbabwean embassy. No translation required. This takes 2-4 weeks.

Step 3: Prepare Your CTD Dossier

Compile CTD dossier (Modules 1-5) in PDF format. MCAZ accepts electronic submissions but paper copies are still common.

Step 4: Pre-Submission Meeting (Recommended)

Your agent should request a meeting with MCAZ evaluators. Highly recommended for first-time applicants to understand expectations.

Step 5: Submission to MCAZ

Your agent submits the dossier (electronic and 2-3 paper copies) to MCAZ in Harare, pays the application fee (USD 200-500), and receives an acknowledgement.

Step 6: Administrative Screening (4-8 weeks)

MCAZ checks for completeness, legalization, and format. Due to capacity constraints, this phase can be lengthy. Follow-up visits are often necessary.

Step 7: Scientific Evaluation (6-12 months)

MCAZ evaluators review quality, bioequivalence (if applicable), and labeling. Queries are communicated via your agent. You have 60-90 days to respond.

Step 8: ZaZiBoNa Verification (if applicable - 1-2 months)

If using the SADC harmonization pathway, MCAZ coordinates with other participating countries.

Step 9: Laboratory Testing (1-3 months)

MCAZ's quality control laboratory in Harare tests product samples. Failure = rejection.

Step 10: GMP Inspection (If Required)

MCAZ may inspect foreign facilities. WHO PQ or SRA approval typically waives inspection.

Step 11: MCAZ Drug Committee Approval (4-8 weeks)

Final approval and certificate issuance.

Dossier Requirements: The MCAZ CTD Format

MCAZ follows the CTD format (Modules 1-5), aligned with WHO and SADC standards.

Module 1: Administrative Information (Zimbabwe-Specific)

• Application letter on manufacturer letterhead
• Cover letter from Zimbabwean agent
• Power of Attorney (legalized)
• Certificate of Pharmaceutical Product (WHO format, legalized, less than 2 years old)
• GMP Certificate (legalized)
• Free Sale Certificate
• Manufacturing license
• Labeling and package insert (English)
• WHO PQ certificate or SRA approval (if available)

Module 2: Summaries

Module 3: Quality

• Stability data: Zimbabwe has a subtropical climate. Zone IV data is recommended.

Module 4: Nonclinical (NCEs only)

Module 5: Clinical/Bioequivalence

• Bioequivalence study report or WHO PQ certificate

Local Agent Requirements: The Mandatory Local Representative

Zimbabwe's local agent requirements are similar to other Southern African markets.

What Your Zimbabwean Agent Must Have:

• Valid MCAZ pharmaceutical import license
• Physical warehouse in Harare or Bulawayo
• Qualified pharmacist on staff
• Experience with MCAZ registration and NatPharm tenders
• Cold chain capability (for temperature-sensitive products)
• Ability to navigate currency challenges (USD/ZWG)

Selecting Your Agent:

• Zimbabwe has approximately 15-25 licensed pharmaceutical importers
• Key players include: Caps Holdings, Datlabs, Pharmawell, and various private importers
• Choose an agent with experience in your therapeutic category and a track record of successful MCAZ registrations
• Ask about their NatPharm tender experience—winning government tenders requires relationships and logistics capability
• Financial stability is critical—currency volatility has impacted many distributors

SADC Alignment & ZaZiBoNa Harmonization

This is the most important strategic consideration for Zimbabwe.

The ZaZiBoNa Collaborative Registration Process:

ZaZiBoNa (Zambia, Zimbabwe, Botswana, Namibia) is a SADC harmonization initiative that also includes South Africa as an observer. Zimbabwe is an active participant, and this collaborative registration process allows a single dossier assessment to be recognized by multiple participating countries.

How ZaZiBoNa works with Zimbabwe:

1. You submit one dossier to the ZaZiBoNa collaborative process through a reference national regulator (which could be MCAZ).
2. A joint team of experts from participating countries assesses the dossier.
3. Once approved at the collaborative level, you obtain individual national registrations from each country—but the scientific assessment is done once.
4. MCAZ accepts the ZaZiBoNa assessment and typically issues the national registration within 1-3 months.

Benefits of Using ZaZiBoNa for Zimbabwe:

• Faster than standalone MCAZ registration (6-10 months assessment vs. 9-15 months)
• Lower total cost for multi-country entry (Zimbabwe, Zambia, Botswana, Namibia, potentially South Africa)
• One set of queries instead of multiple
• MCAZ trusts the collaborative assessment

Using Zimbabwe as Your ZaZiBoNa Reference State:

Zimbabwe can serve as your reference state for the ZaZiBoNa process. This means:

• You submit to MCAZ as the lead regulator
• MCAZ coordinates with other participating countries
• Once MCAZ approves, other countries fast-track

Import Permits & Port Clearance (Beira & Durban)

Zimbabwe is landlocked. Pharmaceutical imports arrive via the ports of Beira (Mozambique) or Durban (South Africa) and are transported by road to Harare or Bulawayo.

The Import Permit Process:

1. Your Zimbabwean agent applies for an import permit from MCAZ.
2. MCAZ issues the permit (typically 5-15 working days).
3. The permit is valid for that specific shipment.

Two Primary Routes:

Route 1: Beira (Mozambique) to Harare

• Most common route (60-70% of imports)
• Clear Mozambique customs at Beira port
• Transport by road (2-3 days to Harare via Mutare border)
• Clear Zimbabwe customs at Mutare or Harare

Route 2: Durban (South Africa) to Harare

• Used for 30-40% of imports
• Clear South Africa customs at Durban port
• Transport by road (5-7 days to Harare via Beitbridge border)
• Clear Zimbabwe customs at Beitbridge or Harare

Timelines & Costs:

• Beira clearance: 5-10 days
• Transport to Harare: 2-3 days
• Harare clearance: 2-5 days
• Total: 9-18 days from ship arrival to Harare warehouse
• Transport cost (Beira-Harare): $2,500-4,500 per 20-foot container
• Transport cost (Durban-Harare): $4,000-6,500 per 20-foot container

GMP Compliance & Facility Inspections

MCAZ's GMP requirements are aligned with WHO GMP standards.

GMP Evidence MCAZ Accepts:

• WHO Prequalification (highest acceptance - waives inspection)
• SRA inspection (US FDA, EMA, SAHPRA) within last 3 years
• SADC joint inspection (ZaZiBoNa)
• MCAZ-conducted inspection (if no other evidence)

When Does MCAZ Conduct Its Own Inspection?

• First-time registration without WHO PQ or SRA evidence
• Suspected GMP issues
• High-risk products (injectables, biologics)

Inspection Process:

1. MCAZ notifies your agent (8-12 weeks notice)
2. Fee: $8,000-15,000 plus travel expenses
3. Inspectors visit for 3-4 days
4. CAPA plan required for findings

Costs, Timelines & Budget Planning

Zimbabwe offers moderate official fees but significant economic uncertainty affects real costs.

Official MCAZ Fees (USD, Approximate)

• Application fee: $200-500
• Evaluation fee: $500-1,500
• Registration certificate: $300-800
• Annual retention fee: $100-300 per product
• Import permit fee: $20-50 per shipment

Note: Fees are typically in USD, but local currency (ZWG) payments may be required. Currency volatility is a significant factor.

Third-Party Costs

• Regulatory consultant fees: $8,000-18,000 per product
• Document legalization: $1,000-2,500
• GMP inspection (if required): $10,000-18,000 plus travel
• Bioequivalence study: $50,000-150,000 if new study needed
• Stability studies: $10,000-25,000
• Local agent fees: $5,000-15,000 annually

Total Estimated Cost Per Product:

• Generic with WHO PQ (fastest): $12,000-22,000
• Generic with ZaZiBoNa: $15,000-28,000 (but covers multiple countries)
• Standard generic (well-prepared): $18,000-35,000
• Generic with MCAZ inspection: $28,000-45,000

Timelines:

• WHO PQ Fast-Track: 5-8 months
• ZaZiBoNa (collaborative assessment): 6-10 months plus national steps
• Standard generic (well-prepared): 9-14 months
• Standard generic (poor dossier, delays): 12-24 months

The Tender System: NatPharm & Procurement

Zimbabwe's public sector procurement is centralized through the National Pharmaceutical Company (NatPharm), which purchases essential medicines for government health facilities.

How NatPharm Tenders Work:

1. NatPharm publishes tender announcements for specific products (by INN name, dosage form, strength).
2. Eligible suppliers (registered importers with MCAZ-registered products) submit bids.
3. NatPharm evaluates bids based on:
   • Price (40-50% weight) - Lowest price wins
   • Product quality (30-40% weight) - WHO PQ preferred
   • Supplier reliability (20% weight) - Previous performance, delivery history
   • Local manufacturing preference (bonus) - Zimbabwe-manufactured products preferred
4. Winning bids receive contracts for specific quantities, delivered to NatPharm central warehouses in Harare.

Private Sector Opportunity:

The private sector accounts for 30-40% of the Zimbabwean pharmaceutical market. Private pharmacies and hospitals purchase registered products through distributors. Margins are higher than NatPharm tenders, but volumes are lower.

Currency Realities: USD vs. ZWG

This is a critical risk factor for Zimbabwe.

Zimbabwe has experienced significant currency volatility, including hyperinflation (2008), dollarization (2009-2019), and the reintroduction of the Zimbabwe Gold (ZWG) currency in 2024.

Key Currency Realities:

• USD preference: Most pharmaceutical transactions are priced in USD, but local payments may be in ZWG at unfavorable exchange rates.
• Exchange rate volatility: The ZWG has depreciated significantly since introduction. Official rates often lag parallel market rates.
• Payment delays: NatPharm and other government entities may pay in ZWG with significant delays.
• Repatriation challenges: Getting USD out of Zimbabwe can be difficult. Many exporters use offshore accounts or intermediaries.

Mitigation Strategies:

• Price in USD in your supply agreement with your local agent
• Require USD payment or index payments to USD exchange rate
• Work with a local agent who has USD bank accounts and strong banking relationships
• Consider using a South African or Dubai-based intermediary for settlements
• Build currency risk into your pricing (expect 10-20% currency loss)

Common Pitfalls & Rejection Reasons

• Invalid or Expired CPP: Less than 2 years old, WHO format required
• Missing Legalization: All foreign documents must be legalized
• Incorrect Reference Product for BE: Must use Zimbabwe-registered reference
• Inadequate Stability Data: Zone IV (tropical) recommended
• GMP Certificate Issues: Expired or not from recognized authority
• No Local Agent Agreement: Valid agent license must be on file
• Product Sample Fails MCAZ Testing: Immediate rejection
• Uncompetitive Pricing: For NatPharm tenders, price is primary factor
• Incomplete Dossier (Missing Modules): MCAZ requires all 5 CTD modules
• Currency Issues: Inability to transact in USD or manage ZWG risk

Post-Registration Obligations & Renewal

• Annual Retention Fees: Payable each year in USD or ZWG
• Variations: Changes require MCAZ approval; timeline 4-8 months
• Renewal: Every 5 years, start 9-12 months before expiry
• Pharmacovigilance: Your agent must report adverse events to MCAZ; PSURs every 2 years
• Post-Market Surveillance: MCAZ samples products; failures lead to recalls
• Tender participation: Actively bid on NatPharm tenders for volume
• Currency management: Continuously monitor exchange rates and adjust pricing

Conclusion: Your Zimbabwe Entry Strategy

Zimbabwe is a challenging but potentially rewarding market for pharmaceutical exporters. The market is large enough (16M people), the regulatory system is functional (if slow), and the SADC harmonization framework (ZaZiBoNa) offers regional access. However, economic volatility, currency instability, and payment delays are significant risks.

Your Zimbabwe registration checklist:

• ✓ Find a financially stable Zimbabwean agent with MCAZ license and NatPharm tender experience
• ✓ Obtain WHO Prequalification for your product (strongly recommended for tenders)
• ✓ Execute and legalize Power of Attorney
• ✓ Obtain valid CPP (WHO format, less than 2 years old)
• ✓ Prepare CTD dossier (English only, no translations needed)
• ✓ Budget $18,000-35,000 per product
• ✓ Plan for 9-14 months for registration (5-8 months with WHO PQ)
• ✓ Use the ZaZiBoNa harmonization pathway if targeting multiple SADC markets
• ✓ Develop competitive pricing for NatPharm tenders
• ✓ Build currency risk mitigation into your pricing (USD indexing)
• ✓ Hire a local regulatory consultant with MCAZ relationships
• ✓ Be patient and persistent—MCAZ moves slowly
• ✓ Consider shorter payment terms to manage currency risk

Is Zimbabwe worth it? For manufacturers with WHO Prequalified products, a low-cost manufacturing base, and tolerance for economic volatility, yes. The market offers regional access through ZaZiBoNa and a population of 16 million. However, Zimbabwe is not for the risk-averse or under-capitalized. Build currency risk into your financial model, choose your local agent carefully (financial stability is critical), and be prepared for delays.

Zimbabwe is the high-risk, high-reward market of Southern Africa. For those who can navigate the challenges, it offers a foothold in the SADC region and a resilient, well-educated market. For those who can't, the currency volatility and payment delays will eat your margins. Choose wisely.